| Kerala Ayurveda Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530163 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE817B01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 28.05 |
Market Cap(₹Cr) : 190.05 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 22.53 | 24.57 | 22.07 | 21.29 | 17.57 | 19.35 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 22.53 | 24.57 | 22.07 | 21.29 | 17.57 | 19.35 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.28 | 4.70 | 0.98 | 2.26 | 10.00 | 4.37 |
| Total Income | 23.81 | 29.27 | 23.04 | 23.55 | 27.56 | 23.72 |
| Total Expenditure | 27.62 | 35.05 | 24.13 | 26.33 | 22.99 | 30.34 |
| PBIDT | -3.82 | -5.79 | -1.09 | -2.78 | 4.57 | -6.62 |
| Interest | 2.81 | 1.97 | 1.98 | 2.54 | 0.77 | 2.81 |
| PBDT | -6.63 | -7.76 | -3.07 | -5.32 | 3.80 | -9.42 |
| Depreciation | 1.41 | 1.24 | 0.58 | 0.55 | 1.23 | 1.46 |
| Tax | -0.36 | -1.07 | -0.18 | -0.47 | 0.51 | 0.98 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -7.67 | -7.93 | -3.47 | -5.40 | 2.07 | -11.86 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -7.67 | -7.93 | -3.47 | -5.40 | 2.07 | -11.86 |
| EPS (Unit Curr.) | -5.92 | -6.25 | -3.03 | -4.58 | 1.73 | -10.13 |
| EPS (Adj) (Unit Curr.) | -5.92 | -6.25 | -3.03 | -4.58 | 1.73 | -10.13 |
| Calculated EPS (Unit Curr.) | -5.90 | -6.25 | -2.88 | -4.48 | 1.72 | -9.86 |
| Calculated EPS (Adj) (Unit Curr.) | -5.90 | -6.25 | -2.88 | -4.48 | 1.72 | -9.86 |
| Calculated EPS (Ann.) (Unit Curr.) | -23.61 | -25.01 | -11.52 | -17.91 | 6.87 | -39.44 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -23.61 | -25.01 | -11.52 | -17.91 | 6.87 | -39.44 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 13.00 | 12.69 | 12.06 | 12.06 | 12.03 | 12.03 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -16.96 | -23.57 | -4.94 | -13.06 | 26.01 | -34.21 |
| PBDTM(%) | -29.43 | -31.58 | -13.91 | -24.99 | 21.63 | -48.68 |
| PATM(%) | -34.04 | -32.28 | -15.72 | -25.36 | 11.78 | -61.29 |
